Today, with the introduction of interferon-free direct-acting antivirals and outstanding
progresses in the prevention, diagnosis and treatment of hepatitis C virus (HCV) infection …

Hepatitis C virus (HCV) infection is still a major public health problem worldwide since its
first identification in 1989. At the start, HCV infection was post-transfusion viral infection …

Viral hepatitis is a cause for major health care burden in India and is now equated as a
threat comparable to the “big three” communicable diseases–HIV/AIDS, malaria and …

Hepatitis C virus (HCV) is a globally prevalent pathogen and is a major cause of healthcare
burden in India. HCV poses a significant problem in the state of Punjab, India owing to the …

Hepatitis C virus (HCV) infection is a major global issue that leads to serious liver disease
such as chronic liver inflammation and hepatocellular carcinoma. At present, no approved …

With the on-going pandemic, vaccine developing methods have gained attention of the
scientific community, specially towards the production, downstream and transport aspects …

Coevolution occurs between viruses and their hosts. The hosts need to evolve means to
eliminate pathogenic virus infections, and the viruses, for their own survival and …

DNA vaccines are widely used to prevent and treat infectious diseases, cancer and
autoimmune diseases; however, their relatively low immunogenicity is an obstacle to their …

Individuals with chronic kidney disease (CKD) are vulnerable to vaccine-preventable
infections due to impaired immunity, immunosuppressive treatments and dialysis. Protection …

Vaccines can have heterologous effects on the immune system, ie, effects other than
triggering an immune response against the disease targeted by the vaccine. We …